A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors
Condition(s):Refractory Solid Tumors; MelanomaLast Updated:February 11, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Refractory Solid Tumors; MelanomaLast Updated:February 11, 2020Completed
Condition(s):Mitochondrial DNA Deletion; MacrocytosisLast Updated:December 29, 2023Not yet recruiting
Condition(s):HealthyLast Updated:July 26, 2012Completed
Condition(s):Colorectal CancerLast Updated:October 22, 2013Terminated
Condition(s):Autism Spectrum Disorder; Language DisordersLast Updated:October 25, 2023Recruiting
Condition(s):Non-Small Cell Lung CancerLast Updated:October 22, 2013Completed
Condition(s):Down SyndromeLast Updated:May 13, 2020Completed
Condition(s):Mucinous Adenocarcinoma of the Colon; Mucinous Adenocarcinoma of the Rectum; Recurrent Colon Cancer; Recurrent Rectal Cancer; Signet Ring Adenocarcinoma of the Colon; Signet Ring Adenocarcinoma of the Rectum; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal CancerLast Updated:May 6, 2015Withdrawn
Condition(s):Actively Extending Plaque Psoriasis; Moderate to Severe Plaque PsoriasisLast Updated:January 9, 2018Completed
Condition(s):Hepatitis CLast Updated:February 15, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.